Phase Forward to Participate in World Drug Safety Congress Europe

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in the 2nd annual World Drug Safety Congress Europe, to be held September 16-19 at the Hilton London Paddington in London, U.K.

MORE ON THIS TOPIC